Literature DB >> 10446863

Th1/Th2 balance of peripheral T helper cells in systemic lupus erythematosus.

M Akahoshi1, H Nakashima, Y Tanaka, T Kohsaka, S Nagano, E Ohgami, Y Arinobu, K Yamaoka, H Niiro, M Shinozaki, H Hirakata, T Horiuchi, T Otsuka, Y Niho.   

Abstract

OBJECTIVE: To analyze the Th1/Th2 balance of peripheral Th cells in patients with systemic lupus erythematosus (SLE).
METHODS: The Th1:Th2 ratio was analyzed in 3 groups: SLE without proteinuria (group I; n = 23), SLE with proteinuria (group II; n = 31), and normal controls (group III; n = 24). Group II patients who had undergone renal biopsy were classified into 3 subgroups based on their renal histopathologic findings. The intracellular cytokine detection method with flow cytometry was used to quantitate Th1 and Th2 cells.
RESULTS: There was no difference in the mean Th1:Th2 ratio between SLE patients (groups I and II) and healthy controls (group III). However, the mean value in group II was significantly higher than those in groups I and III. Moreover, within group II, the mean value in SLE patients who had diffuse proliferative lupus nephritis (World Health Organization class IV) was especially high.
CONCLUSION: Although SLE has been considered to be a disease in which Th2 cells predominate, the Th1/Th2 balance of peripheral Th cells in SLE patients in the present study did not show a predominance of these cells. In contrast, among SLE patients with WHO class IV lupus nephritis, there was a strong predominance of Th1.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10446863     DOI: 10.1002/1529-0131(199908)42:8<1644::AID-ANR12>3.0.CO;2-L

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  81 in total

1.  The Th1/Th2 cytokine balance changes with the progress of the immunopathological lesion of Sjogren's syndrome.

Authors:  D I Mitsias; A G Tzioufas; C Veiopoulou; E Zintzaras; I K Tassios; O Kogopoulou; H M Moutsopoulos; G Thyphronitis
Journal:  Clin Exp Immunol       Date:  2002-06       Impact factor: 4.330

2.  Mechanistic target of rapamycin complex 1 expands Th17 and IL-4+ CD4-CD8- double-negative T cells and contracts regulatory T cells in systemic lupus erythematosus.

Authors:  Hiroshi Kato; Andras Perl
Journal:  J Immunol       Date:  2014-03-28       Impact factor: 5.422

Review 3.  Interferon-γ and systemic autoimmunity.

Authors:  Kenneth M Pollard; David M Cauvi; Christopher B Toomey; Kevin V Morris; Dwight H Kono
Journal:  Discov Med       Date:  2013-09       Impact factor: 2.970

Review 4.  Pathogenic immunity in systemic lupus erythematosus and atherosclerosis: common mechanisms and possible targets for intervention.

Authors:  M Wigren; J Nilsson; M J Kaplan
Journal:  J Intern Med       Date:  2015-11       Impact factor: 8.989

Review 5.  Oxidative Modifications in Tissue Pathology and Autoimmune Disease.

Authors:  Mei-Ling Yang; Hester A Doyle; Steven G Clarke; Kevan C Herold; Mark J Mamula
Journal:  Antioxid Redox Signal       Date:  2017-12-11       Impact factor: 8.401

6.  Targeting the CD134-CD134L interaction using anti-CD134 and/or rhCD134 fusion protein as a possible strategy to prevent lupus nephritis.

Authors:  Yan-bin Zhou; Ren-gao Ye; You-ji Li; Can-mao Xie
Journal:  Rheumatol Int       Date:  2008-09-20       Impact factor: 2.631

Review 7.  Anti-ribosomal P antibodies and lupus nephritis.

Authors:  Shunsei Hirohata
Journal:  Clin Exp Nephrol       Date:  2011-06-07       Impact factor: 2.801

8.  Lupus autoimmunity altered by cellular methylation metabolism.

Authors:  Mei-Ling Yang; Alaric J P Gee; Renelle J Gee; Cecilia I Zurita-Lopez; Shilpi Khare; Steven G Clarke; Mark J Mamula
Journal:  Autoimmunity       Date:  2012-11-01       Impact factor: 2.815

9.  Association of interferon-gamma gene polymorphism (+874A) with arthritis manifestation in SLE.

Authors:  Marut Tangwattanachuleeporn; Pimpayao Sodsai; Yingyos Avihingsanon; Jongkonnee Wongpiyabovorn; Jeerapat Wongchinsri; Nattiya Hirankarn
Journal:  Clin Rheumatol       Date:  2007-08-23       Impact factor: 2.980

10.  Hypomethylation of IL10 and IL13 promoters in CD4+ T cells of patients with systemic lupus erythematosus.

Authors:  Ming Zhao; Jinling Tang; Fei Gao; Xiaoyan Wu; Yunsheng Liang; Heng Yin; Qianjin Lu
Journal:  J Biomed Biotechnol       Date:  2010-06-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.